FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

8825611000001100: Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1864641000001119 Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1864651000001116 Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Is a Cephalexin 500mg/5mL syrup false Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has active ingredient Cefalexin true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral syrup true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has specific active ingredient Cefalexin true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Is a Cefalexin 500mg/5ml oral suspension false Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Is a Cefalexin 500mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Is pack of False Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) 100 ml Has AMP True Cefalexin 500mg/5ml oral suspension (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start